GPR109A/HCAR2 plays a significant role in regulating the blood–retinal barrier’s integrity and has therapeutic potential toward preventing and treating retinal diseases such as diabetic retinopathy, in which the compromised barrier function is of paramount importance [74]. Here, HCAR2 is linked to diabetic retinopathy.